1.
2.
CMAJ
; 193(12): E425, 2021 03 22.
Article
in English
| MEDLINE
| ID: mdl-33753367
Subject(s)
Chickenpox/pathology , Sunlight/adverse effects , Ultraviolet Rays/adverse effects , Child, Preschool , Humans , Male
3.
J Dermatol
; 47(1): e22-e23, 2020 Jan.
Article
in English
| MEDLINE
| ID: mdl-31631389
Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Complement Inactivating Agents/therapeutic use , Epoprostenol/analogs & derivatives , Malignant Atrophic Papulosis/drug therapy , Prostaglandins, Synthetic/therapeutic use , Adult , Anticoagulants/therapeutic use , Cerebral Hemorrhage/diagnostic imaging , Cerebral Hemorrhage/etiology , Combined Modality Therapy , Epoprostenol/therapeutic use , Fatal Outcome , Glucocorticoids/therapeutic use , Humans , Intestinal Perforation/etiology , Male , Malignant Atrophic Papulosis/complications , Malignant Atrophic Papulosis/pathology , Prognosis , Treatment Outcome
4.
JAMA Dermatol
; 156(2): 204, 2020 02 01.
Article
in English
| MEDLINE
| ID: mdl-31799991
5.
J Am Acad Dermatol
; 82(3): 770-772, 2020 03.
Article
in English
| MEDLINE
| ID: mdl-31734192
Subject(s)
Antibodies, Monoclonal, Humanized/adverse effects , Antineoplastic Agents, Immunological/adverse effects , Drug Eruptions/etiology , Melanoma/drug therapy , Nivolumab/adverse effects , Programmed Cell Death 1 Receptor/antagonists & inhibitors , Skin Neoplasms/drug therapy , Vitiligo/chemically induced , Adult , Aged , Aged, 80 and over , Antibodies, Monoclonal, Humanized/therapeutic use , Antineoplastic Agents, Immunological/therapeutic use , Female , Humans , Male , Melanoma/mortality , Middle Aged , Nivolumab/therapeutic use , Retrospective Studies , Skin Neoplasms/mortality , Survival Rate
6.
Acta Derm Venereol
; 100(1): adv00014, 2020 Jan 07.
Article
in English
| MEDLINE
| ID: mdl-31709451
Subject(s)
Antibodies, Monoclonal, Humanized/administration & dosage , Dermatitis, Atopic/drug therapy , Dermatologic Agents/administration & dosage , Skin/drug effects , Adolescent , Age Factors , Antibodies, Monoclonal, Humanized/adverse effects , Dermatitis, Atopic/pathology , Dermatologic Agents/adverse effects , Female , Humans , Male , Patient Safety , Remission Induction , Retrospective Studies , Risk Factors , Severity of Illness Index , Skin/pathology , Treatment Outcome
7.
Eur J Dermatol
; 29(5): 572-573, 2019 Oct 01.
Article
in English
| MEDLINE
| ID: mdl-31789285
Subject(s)
Facial Dermatoses/pathology , Granuloma/pathology , Aged , Biopsy , Humans , Male , Skin/pathology
8.
Eur J Dermatol
; 29(5): 564-565, 2019 Oct 01.
Article
in English
| MEDLINE
| ID: mdl-31647460